Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1354275rdf:typepubmed:Citationlld:pubmed
pubmed-article:1354275lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:1354275lifeskim:mentionsumls-concept:C0031001lld:lifeskim
pubmed-article:1354275lifeskim:mentionsumls-concept:C1319315lld:lifeskim
pubmed-article:1354275lifeskim:mentionsumls-concept:C0085533lld:lifeskim
pubmed-article:1354275lifeskim:mentionsumls-concept:C0728940lld:lifeskim
pubmed-article:1354275lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:1354275lifeskim:mentionsumls-concept:C1880198lld:lifeskim
pubmed-article:1354275pubmed:issue8818lld:pubmed
pubmed-article:1354275pubmed:dateCreated1992-9-17lld:pubmed
pubmed-article:1354275pubmed:abstractTextAbout half the patients treated with curative resection for colorectal cancer do not survive long-term. Adjuvant chemotherapy given during and after surgery may prevent hepatic metastases and improve patient survival. In patients with colorectal cancer, we have done a multicentre, randomised controlled trial comparing five-year survival after intraportal infusion of fluorouracil (1 g per day) plus heparin (10,000 U per day) (130 patients) or heparin alone (123) during curative resection and for 7 days thereafter, or after resection alone (145). There was no reduction in liver metastasis or increased overall survival advantage in either active-treatment arm of the study. However, patients who had stage III, Dukes' C (lymph-node-positive) tumours resected and were treated with fluorouracil plus heparin had a significant (p less than 0.03) survival advantage of about 16% compared with surgery-only controls. Further study of intraportal infusion of chemotherapeutic agent as adjuvant treatment to surgery in patients with colorectal cancer appears worthwhile.lld:pubmed
pubmed-article:1354275pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1354275pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1354275pubmed:languageenglld:pubmed
pubmed-article:1354275pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1354275pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1354275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1354275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1354275pubmed:statusMEDLINElld:pubmed
pubmed-article:1354275pubmed:monthAuglld:pubmed
pubmed-article:1354275pubmed:issn0140-6736lld:pubmed
pubmed-article:1354275pubmed:authorpubmed-author:FieldingL PLPlld:pubmed
pubmed-article:1354275pubmed:authorpubmed-author:HittingerRRlld:pubmed
pubmed-article:1354275pubmed:authorpubmed-author:GraceR HRHlld:pubmed
pubmed-article:1354275pubmed:authorpubmed-author:NEYL FLFlld:pubmed
pubmed-article:1354275pubmed:issnTypePrintlld:pubmed
pubmed-article:1354275pubmed:day29lld:pubmed
pubmed-article:1354275pubmed:volume340lld:pubmed
pubmed-article:1354275pubmed:ownerNLMlld:pubmed
pubmed-article:1354275pubmed:authorsCompleteYlld:pubmed
pubmed-article:1354275pubmed:pagination502-6lld:pubmed
pubmed-article:1354275pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:meshHeadingpubmed-meshheading:1354275-...lld:pubmed
pubmed-article:1354275pubmed:year1992lld:pubmed
pubmed-article:1354275pubmed:articleTitleRandomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma.lld:pubmed
pubmed-article:1354275pubmed:affiliationAcademic Surgical Unit, St Mary's Hospital, London, UK.lld:pubmed
pubmed-article:1354275pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1354275pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1354275pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:1354275pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:1354275pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1354275lld:pubmed